HomeRVU • WSE
add
Ryvu Therapeutics SA
Previous close
zł 46.20
Day range
zł 44.20 - zł 46.65
Year range
zł 39.50 - zł 67.10
Market cap
1.02B PLN
Avg Volume
7.52K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 25.03M | 54.15% |
Operating expense | 45.09M | 17.59% |
Net income | -26.56M | -45.53% |
Net profit margin | -106.13 | 5.60% |
Earnings per share | — | — |
EBITDA | -22.69M | -0.53% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 247.55M | -4.22% |
Total assets | 403.18M | -8.33% |
Total liabilities | 225.43M | 46.83% |
Total equity | 177.75M | — |
Shares outstanding | 23.12M | — |
Price to book | 6.01 | — |
Return on assets | -15.55% | — |
Return on capital | -23.99% | — |
Cash Flow
Net change in cash
| (PLN) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -26.56M | -45.53% |
Cash from operations | -36.26M | -405.59% |
Cash from investing | 76.51M | 1,501.23% |
Cash from financing | 23.59M | 6,652.78% |
Net change in cash | 64.00M | 553.63% |
Free cash flow | -15.27M | 45.93% |
About
Founded
2007
Website
Employees
270
